Cas:885266-61-5 3-(4-tert-Butoxyphenyl)butyric acid manufacturer & supplier

Chemical Name:3-(4-tert-Butoxyphenyl)butyric acid

CAS.NO:885266-61-5

Synonyms:3-(4-tert-Butoxyphenyl)butyric acid

Molecular Formula:C₁₄H₂₀O₃

Molecular Weight:236.30700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:46.53000

Exact Mass:236.14100

LogP:3.44210

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-(4-tert-Butoxyphenyl)butyric acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(4-tert-Butoxyphenyl)butyric acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(4-tert-Butoxyphenyl)butyric acid Use and application,3-(4-tert-Butoxyphenyl)butyric acid technical grade,usp/ep/jp grade.

Related News: Retrogenix��s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding. 3-(4-tert-Butoxyphenyl)butyric acid manufacturer The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs. 3-(4-tert-Butoxyphenyl)butyric acid supplier As far as chemical raw materials are concerned, China occupies a large share in the field of bulk raw materials and has become one of the world’s largest suppliers of chemical raw materials. 3-(4-tert-Butoxyphenyl)butyric acid vendor Retrogenix��s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding. 3-(4-tert-Butoxyphenyl)butyric acid factory Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection.